Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00713349 · ClinicalTrials.gov registry record · Phase 2
Controlled Study of the Effect of Xenaderm® Ointment Vehicle Versus White Petrolatum on Healing
A Phase 2 study, sponsored by Healthpoint.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT00713349 is a Phase 2 study that has completed, run by Healthpoint. The registered enrollment target is 25 participants.
The verdict
NCT00713349, a Phase 2 study, has completed, sponsored by Healthpoint.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
The objective of the study is to compare the healing of wounds induced by cryo-injury when treated with white petrolatum versus an ointment vehicle.
Interventions
- OTHER Placebo comparator
- DRUG Xenaderm Vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00713349
The ClinicalTrials.gov registry entry for NCT00713349 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthpoint, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo comparator is the first listed.
NCT00713349 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00713349 about?
NCT00713349 is a clinical study titled "Controlled Study of the Effect of Xenaderm® Ointment Vehicle Versus White Petrolatum on Healing". The objective of the study is to compare the healing of wounds induced by cryo-injury when treated with white petrolatum versus an ointment vehicle.
What is the current status of trial NCT00713349?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2008-06. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00713349?
The interventions under investigation include: Placebo comparator (OTHER), Xenaderm Vehicle (DRUG).
Who is sponsoring clinical trial NCT00713349?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.